Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone

J Infect Dis. 2018 May 18;217(suppl_1):S48-S55. doi: 10.1093/infdis/jix336.

Authors

Affiliations

¹ College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
² Conceptual Mindworks, Washington, D. C.
³ Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ Modality Solutions, League City, Texas.
⁵ Global Good, Intellectual Ventures, Bellevue, Washington.

Abstract

ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Disease Outbreaks*
Ebola Vaccines / administration & dosage
Ebola Vaccines / supply & distribution*
Freezing*
Hemorrhagic Fever, Ebola / epidemiology*
Hemorrhagic Fever, Ebola / prevention & control*
Humans
Refrigeration / methods*
Sierra Leone / epidemiology

Substances

Ebola Vaccines

Associated data

ClinicalTrials.gov/NCT02378753
PACTR/PACTR201502001037220